{
      "Rank": 1,
      "Acronym": [
            "ARTROCELL"
      ],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "Treatment with 40 millions of autologous autologous adult mesenchymal stem cells from expanded bone marrow administered intra-articularly.",
            "Treatment with 40 millions of adult allogeneic expanded bone marrow mesenchymal stem cells administered intra-articularly.",
            "Hyaluronic Acid 60mg/3ml administered intra-articularly."
      ],
      "ArmGroupInterventionName": [
            "Drug: Autologous MSCs",
            "Drug: Allogenic MSCs",
            "Drug: Hyaluronic Acid"
      ],
      "ArmGroupLabel": [
            "Autologous Mesenchymal Stromal Cells (MSC)",
            "Allogenic Mesenchymal Stromal Cells (MSC)",
            "Active Control"
      ],
      "ArmGroupType": [
            "Experimental",
            "Experimental",
            "Active Comparator"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT05086939"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "Phase III, multicenter, randomized, open-label, multicenter clinical trial comparing treatment with allogeneic mesenchymal cells versus autologous mesenchymal cells and versus active control with hyaluronic acid in patients with knee osteoarthritis."
      ],
      "BriefTitle": [
            "Multicenter Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis."
      ],
      "CentralContactEMail": [],
      "CentralContactName": [],
      "CentralContactPhone": [],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [],
      "CollaboratorClass": [
            "OTHER",
            "NETWORK",
            "OTHER",
            "OTHER"
      ],
      "CollaboratorName": [
            "Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca",
            "Spanish Clinical Research Network - SCReN",
            "Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer",
            "Hospital Universitari de Bellvitge"
      ],
      "CompletionDate": [
            "December 2025"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Knee Osteoarthritis"
      ],
      "ConditionAncestorId": [
            "D000001168",
            "D000007592",
            "D000009140",
            "D000012216"
      ],
      "ConditionAncestorTerm": [
            "Arthritis",
            "Joint Diseases",
            "Musculoskeletal Diseases",
            "Rheumatic Diseases"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC05",
            "All",
            "BC17"
      ],
      "ConditionBrowseBranchName": [
            "Musculoskeletal Diseases",
            "All Conditions",
            "Skin and Connective Tissue Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Osteoarthritis",
            "Knee Osteoarthritis"
      ],
      "ConditionBrowseLeafId": [
            "M12078",
            "M21321",
            "M3628",
            "M9773",
            "M11249",
            "M14197",
            "M5475"
      ],
      "ConditionBrowseLeafName": [
            "Osteoarthritis",
            "Osteoarthritis, Knee",
            "Arthritis",
            "Joint Diseases",
            "Musculoskeletal Diseases",
            "Rheumatic Diseases",
            "Collagen Diseases"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000010003",
            "D000020370"
      ],
      "ConditionMeshTerm": [
            "Osteoarthritis",
            "Osteoarthritis, Knee"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Randomized"
      ],
      "DesignInterventionModel": [
            "Parallel Assignment"
      ],
      "DesignInterventionModelDescription": [
            "Randomized, Open-label, Clinical Trial comparing 3 active treatments."
      ],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nKnee osteoarthritis Kellgren-Lawrence grade 2, 3 or 4 .\nChronic painful knee of mechanical characteristics.\nAbsence of local or systemic septic process.\nHemacytometric and biochemical analysis without significant alterations that contraindicate treatment.\nWritten informed consent of the patient.\nThe patient is able to understand the nature of the study.\nNEGATIVE serologies: Syphilis, HTLVI-II, HIV, Hepatitis B virus (HBV), Hepatitis C virus (HCV) and HCV Polymerase chain reaction (PCR) (must be repeated if more than 30 days elapse between its completion and the extraction of bone marrow in patients to whom autologous cells correspond).\nBody Mass Index 20-35 Kg/m2.\n\nExclusion Criteria:\n\nPatient < 18 years old, or legally dependent.\nPatient > 75 years old.\nCongenital or evolutive diseases that result in malformation and/or significant deformities of the knee (varus<10\u00ba; valgus<20\u00ba) that cause difficulties in the application and evaluation of the results.\nPregnant or breastfeeding women.\nNeoplastic disease.\nIntra-articular infiltration of any drug in the 3 months prior to inclusion in the study.\nConcurrent participation in another clinical trial or treatment with another investigational product in the 30 days prior to inclusion in the study.\nAllergy to gentamicin (antibiotic used in the cell culture process).\nOther diseases or circumstances that may compromise the participation in the study according to medical criteria."
      ],
      "EnrollmentCount": [
            "120"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [
            "No"
      ],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [
            "D000000276",
            "D000007155",
            "D000045505",
            "D000055675",
            "D000020011"
      ],
      "InterventionAncestorTerm": [
            "Adjuvants, Immunologic",
            "Immunologic Factors",
            "Physiological Effects of Drugs",
            "Viscosupplements",
            "Protective Agents"
      ],
      "InterventionArmGroupLabel": [
            "Autologous Mesenchymal Stromal Cells (MSC)",
            "Allogenic Mesenchymal Stromal Cells (MSC)",
            "Active Control"
      ],
      "InterventionBrowseBranchAbbrev": [
            "All"
      ],
      "InterventionBrowseBranchName": [
            "All Drugs and Chemicals"
      ],
      "InterventionBrowseLeafAsFound": [
            "Ratio"
      ],
      "InterventionBrowseLeafId": [
            "M9030",
            "M2780",
            "M9353",
            "M27448",
            "M21022"
      ],
      "InterventionBrowseLeafName": [
            "Hyaluronic Acid",
            "Adjuvants, Immunologic",
            "Immunologic Factors",
            "Viscosupplements",
            "Protective Agents"
      ],
      "InterventionBrowseLeafRelevance": [
            "high",
            "low",
            "low",
            "low",
            "low"
      ],
      "InterventionDescription": [
            "Intra-articular injection 40 million/4 ml.",
            "Intra-articular injection 40 million/4 ml.",
            "Intra-articular injection 60mg / 3 ml ."
      ],
      "InterventionMeshId": [
            "D000006820"
      ],
      "InterventionMeshTerm": [
            "Hyaluronic Acid"
      ],
      "InterventionName": [
            "Autologous MSCs",
            "Allogenic MSCs",
            "Hyaluronic Acid"
      ],
      "InterventionOtherName": [
            "Hyaluronic Acid 20 mg/ml"
      ],
      "InterventionType": [
            "Drug",
            "Drug",
            "Drug"
      ],
      "IsFDARegulatedDevice": [
            "No"
      ],
      "IsFDARegulatedDrug": [
            "No"
      ],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [],
      "LastUpdatePostDate": [
            "June 2, 2022"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "May 27, 2022"
      ],
      "LeadSponsorClass": [
            "OTHER"
      ],
      "LeadSponsorName": [
            "Fundaci\u00f3n Instituto de Estudios de Ciencias de la Salud de Castilla y Le\u00f3n"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Barcelona",
            "Madrid",
            "Madrid",
            "Madrid",
            "Murcia",
            "M\u00e1laga",
            "Pamplona",
            "Salamanca",
            "Valladolid"
      ],
      "LocationContactEMail": [
            "ecalvo@fjd.es",
            "esperanza.lopez@scren.es",
            "jvaquero@salud.madrid.org",
            "esperanza.lopez@scren.es",
            "pmartinezvi@secot.es",
            "esperanza.lopez@scren.es",
            "jmgomezpalomo@gmail.com",
            "esperanza.lopez@scren.es",
            "jlamodeespi@unav.es",
            "esperanza.lopez@scren.es",
            "jfblanco@usal.es",
            "esperanza.lopez@scren.es"
      ],
      "LocationContactName": [
            "Andr\u00e9s Comballa Aleu",
            "Emilio Calvo Crespo",
            "Esperanza L\u00f3pez Franco",
            "Emilio Calvo Crespo",
            "Javier Vaquero Mart\u00edn",
            "Esperanza L\u00f3pez Franco",
            "Javier Vaquero Mart\u00edn",
            "Pedro A Mart\u00ednez Victorio",
            "Esperanza L\u00f3pez Franco",
            "Pedro A. Mart\u00ednez Victorio",
            "Juan M G\u00f3mez Palomo",
            "Esperanza L\u00f3pez Franco",
            "Juan M G\u00f3mez Palomo",
            "Jos\u00e9 M\u00aa Lamo-Espinosa",
            "Esperanza L\u00f3pez Franco",
            "Jos\u00e9 M\u00aa Lamo-Espinosa",
            "Juan F Blanco",
            "Esperanza L\u00f3pez Franco",
            "Juan F Blanco"
      ],
      "LocationContactPhone": [
            "+34 915504800",
            "+34 923291100",
            "+34 915868000",
            "+34 923291100",
            "+34 968369500",
            "+34 923291100",
            "+34 951032000",
            "+34 923291100",
            "+34 948 255400",
            "923 291100",
            "+34 923 291100",
            "+34 923 291100"
      ],
      "LocationContactPhoneExt": [
            "55779"
      ],
      "LocationContactRole": [
            "Principal Investigator",
            "Contact",
            "Contact",
            "Principal Investigator",
            "Contact",
            "Contact",
            "Principal Investigator",
            "Contact",
            "Contact",
            "Principal Investigator",
            "Contact",
            "Contact",
            "Principal Investigator",
            "Contact",
            "Contact",
            "Principal Investigator",
            "Contact",
            "Contact",
            "Principal Investigator"
      ],
      "LocationCountry": [
            "Spain",
            "Spain",
            "Spain",
            "Spain",
            "Spain",
            "Spain",
            "Spain",
            "Spain",
            "Spain"
      ],
      "LocationFacility": [
            "Hospital Clinic",
            "Hospital Cl\u00ednico Universitario San Carlos",
            "Hospital Fundaci\u00f3n Jim\u00e9nez D\u00edaz",
            "Hospital Gregorio Mara\u00f1\u00f3n",
            "Hospital Universitario Virgen de la Arrixaca",
            "Hospital Universitario Virgen de la Victoria",
            "Cl\u00ednica Universidad de Navarra",
            "Complejo Asistencial Universitario de Salamanca",
            "Hospital Cl\u00ednico Universitario de Valladolid"
      ],
      "LocationState": [],
      "LocationStatus": [
            "Not yet recruiting",
            "Suspended",
            "Recruiting",
            "Recruiting",
            "Recruiting",
            "Recruiting",
            "Recruiting",
            "Recruiting",
            "Active, not recruiting"
      ],
      "LocationZip": [
            "37007"
      ],
      "MaximumAge": [
            "75 Years"
      ],
      "MinimumAge": [
            "18 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "Phase III, Multicenter, Randomized, Open-label Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis"
      ],
      "OrgClass": [
            "OTHER"
      ],
      "OrgFullName": [
            "Fundaci\u00f3n Instituto de Estudios de Ciencias de la Salud de Castilla y Le\u00f3n"
      ],
      "OrgStudyId": [
            "ARTROCELL"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "IBSAL - University Hospital of Salamanca"
      ],
      "OverallOfficialName": [
            "Ferm\u00edn S\u00e1nchez-Guijo"
      ],
      "OverallOfficialRole": [
            "Principal Investigator"
      ],
      "OverallStatus": [
            "Recruiting"
      ],
      "OversightHasDMC": [
            "No"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 3"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "December 2025"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [
            "Evaluation of clinical-functional response using Joint range-of-motion evaluation (Flexion score 0\u00ba-140\u00ba / Extension score -140\u00ba-0\u00ba / Hyperextension: positive degrees from 0).",
            "Evaluation of pain using Visual Analogue Scale (VAS) (Pain self-assessment score range from 0 -no pain- to 10 -maximum-).",
            "Evaluation of Knee Osteoarthritis using Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) [measures five items for pain (score range from 0 -no pain- to 20 -maximum-), two for stiffness (score range from 0-no stiffness- to 8 -maximum-), and 17 for functional limitation (score range from 0 -no limitation- to 68 -maximum-)]",
            "Evaluation of functional response using Lequesne Algofunctional Index (score range from 0 to 24). It includes measures of pain (5 questions), walking distance (1 question) and activities of daily living (4 questions) with separate versions for the hip and knee. The scores for each question are summed to obtain a combined score of disease severity. Scores 1 to 4 are classified as mild osteoarthrosis; 5 to 7, moderate; 8 to 10, severe; 11 to 13, very severe; and 14 and above, extremely severe.",
            "Radiological response using Kellgren and Lawrence classification system (grade from 0 to 4):\n\ngrade 0 (none): definite absence of x-ray changes of osteoarthritis.\ngrade 1 (doubtful): doubtful joint space narrowing and possible osteophytic lipping.\ngrade 2 (minimal): definite osteophytes and possible joint space narrowing.\ngrade 3 (moderate): moderate multiple osteophytes, definite narrowing of joint space and some sclerosis and possible deformity of bone ends.\ngrade 4 (severe): large osteophytes, marked narrowing of joint space, severe sclerosis and definite deformity of bone ends.",
            "Evaluation of radiological response using T2 mapping nuclear magnetic resonance imaging (screening visit global mean of T2 values versus 12 months visit global mean of T2 values)."
      ],
      "PrimaryOutcomeMeasure": [
            "Range of motion.",
            "Pain self-assessment.",
            "Knee Osteoarthritis.",
            "Functional response.",
            "X-ray changes of osteoarthritis.",
            "Radiological response using nuclear magnetic resonance imaging."
      ],
      "PrimaryOutcomeTimeFrame": [
            "12 months",
            "12 months",
            "12 months",
            "12 months",
            "12 months",
            "12 months"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [
            "2019-002446-21"
      ],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [
            "EudraCT Number"
      ],
      "SecondaryOutcomeDescription": [
            "Evaluation of quality of life using Short Form-12 Health Survey questionnaire (SF12) [score range from 0 (the worst health status for that dimension) to 100 (the best health status)]",
            "Rate of products not conforming to the validation criteria in each arm of experimental treatment.",
            "Rate of adverse events and other pharmacovigilance parameters in the three treatment arms."
      ],
      "SecondaryOutcomeMeasure": [
            "Perceived general well-being.",
            "Feasibility assessment of a multicentre strategy production of both cell types with several Cell Production Units",
            "Evaluation of presence of adverse events related with investigational medical product (IMP)."
      ],
      "SecondaryOutcomeTimeFrame": [
            "6, 12 and 24 months",
            "24 months",
            "24 months"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "May 26, 2021"
      ],
      "StartDateType": [
            "Actual"
      ],
      "StatusVerifiedDate": [
            "May 2022"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "October 21, 2021"
      ],
      "StudyFirstPostDateType": [
            "Actual"
      ],
      "StudyFirstSubmitDate": [
            "July 5, 2021"
      ],
      "StudyFirstSubmitQCDate": [
            "October 8, 2021"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 07, 2022"
      ],
      "WhyStopped": []
}